Evidence map›Paper›PMID 32658569›Full record

SynthesisAnnals of internal medicine2020

Conversion of Urine Protein-Creatinine Ratio or Urine Dipstick Protein to Urine Albumin-Creatinine Ratio for Use in Chronic Kidney Disease Screening and Prognosis : An Individual Participant-Based Meta-analysis.

Keiichi Sumida, Girish N Nadkarni, Morgan E Grams, Yingying Sang, Shoshana H Ballew, Josef Coresh, Kunihiro Matsushita, Aditya Surapaneni, Nigel Brunskill, Steve J Chadban and 26 more

Open access · greenAbstract readMeta-Analysis
In one paragraph

Synthesis in Annals of internal medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 207 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
207citing papers in PubMed, 6 pooled it
19.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

207 citing papers in PubMed, 6 syntheses or guidelines pooled it, 307 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Trial
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Association of UACR and UPCR with kidney failure: analysis of observational data in patients with rare kidney diseases.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2026
    Observational
  18. Association of UACR and UPCR with kidney failure: a pooled analysis of clinical trials.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2026
    Article
  19. Article
  20. Article

147 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

36 authors at 20 institutions in 8 countries.

Keiichi SumidaUniversity of Tennessee Health Science Center, Memphis, Tennessee (K.S.).
Girish N NadkarniIcahn School of Medicine at Mount Sinai, New York, New York (G.N.N.).
Morgan E GramsJohns Hopkins Bloomberg School of Public Health, Baltimore, Maryland (M.E.G., Y.S., S.H.B., J.C., K.M., A.S.).ORCID 0000-0002-4430-6023
Yingying SangJohns Hopkins Bloomberg School of Public Health, Baltimore, Maryland (M.E.G., Y.S., S.H.B., J.C., K.M., A.S.).
Shoshana H BallewJohns Hopkins Bloomberg School of Public Health, Baltimore, Maryland (M.E.G., Y.S., S.H.B., J.C., K.M., A.S.).ORCID 0000-0002-7547-3764
Josef CoreshJohns Hopkins Bloomberg School of Public Health, Baltimore, Maryland (M.E.G., Y.S., S.H.B., J.C., K.M., A.S.).ORCID 0000-0002-4598-0669
Kunihiro MatsushitaJohns Hopkins Bloomberg School of Public Health, Baltimore, Maryland (M.E.G., Y.S., S.H.B., J.C., K.M., A.S.).ORCID 0000-0002-7179-718X
Aditya SurapaneniJohns Hopkins Bloomberg School of Public Health, Baltimore, Maryland (M.E.G., Y.S., S.H.B., J.C., K.M., A.S.).
Nigel BrunskillLeicester General Hospital, University Hospitals of Leicester NHS Trust, and University of Leicester, Leicester, United Kingdom (N.B., R.W.M.).ORCID 0000-0002-7109-7108
Steve J ChadbanRoyal Prince Alfred Hospital and Kidney Node, University of Sydney, Sydney, New South Wales, Australia (S.J.C.).ORCID 0000-0002-0527-898X
Alex R ChangGeisinger Health, Danville, Pennsylvania (A.R.C.).ORCID 0000-0002-8114-7447
Massimo CirilloUniversity of Naples "Federico II," Naples, Italy (M.C.).ORCID 0000-0002-6409-3504
Kenn B DarathaProvidence Sacred Heart Medical Center and Gonzaga University School of Anesthesia, Spokane, Washington (K.B.D.).ORCID 0000-0002-9194-4140
Ron T GansevoortUniversity Medical Center Groningen, University of Groningen, Groningen, the Netherlands (R.T.G.).
Amit X GargICES and Western University, London, Ontario, Canada (A.X.G.).
Licia IacovielloIRCCS Neuromed, Pozzilli, Italy, and University of Insubria, Varese, Italy (L.I.).ORCID 0000-0003-0514-5885
Takamasa KayamaYamagata University, Yamagata, Japan (T.K., T.K.).
Tsuneo KontaYamagata University, Yamagata, Japan (T.K., T.K.).
Csaba P KovesdyMemphis Veterans Affairs Medical Center and University of Tennessee Health Science Center, Memphis, Tennessee (C.P.K.).ORCID 0000-0002-8204-911X
James LashUniversity of Illinois at Chicago, Chicago, Illinois (J.L.).
Brian J LeeKaiser Permanente, Hawaii Region, and Moanalua Medical Center, Honolulu, Hawaii (B.J.L.).ORCID 0000-0002-7580-8288
Rupert W MajorLeicester General Hospital, University Hospitals of Leicester NHS Trust, and University of Leicester, Leicester, United Kingdom (N.B., R.W.M.).ORCID 0000-0003-4920-623X
Marie MetzgerParis Saclay University, Paris-Sud University, UVSQ, CESP, INSERM U1018, Villejuif, France (M.M.).
Katsuyuki MiuraShiga University of Medical Science Seta-Tsukinowa-cho, Shiga, Japan (K.M.).ORCID 0000-0002-2646-9582
David M J NaimarkSunnybrook Hospital, University of Toronto, Toronto, Ontario, Canada (D.M.N.).ORCID 0000-0002-0621-0637
Robert G NelsonNational Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Phoenix, Arizona (R.G.N.).
Simon SawhneyUniversity of Aberdeen, Aberdeen, Scotland (S.S.).ORCID 0000-0002-7960-4573
Nikita StempniewiczAmerican Medical Group Association, Alexandria, Virginia (N.S.).
Mila TangUniversity of British Columbia, Vancouver, British Columbia, Canada (M.T.).
Raymond R TownsendPerelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania (R.R.T.).ORCID 0000-0002-3215-9118
Jamie P TraynorQueen Elizabeth University Hospital, Glasgow, Scotland (J.P.T.).ORCID 0000-0002-4339-0366
José M ValdivielsoInstitute of Biomedical Research of Lleida and Spanish Research Network for Renal Diseases, Lleida, Spain (J.M.V.).ORCID 0000-0003-1343-0184
Jack WetzelsRadboud University Medical Center, Nijmegen, the Netherlands (J.W.).ORCID 0000-0002-0650-6921
Kevan R PolkinghorneMonash University, Clayton, Victoria, Australia (K.R.P.).
Hiddo J L HeerspinkUniversity of Groningen, University Medical Center, Groningen, the Netherlands, and The George Institute for Global Health, Sydney, New South Wales, Australia (H.J.H.).
Chronic Kidney Disease Prognosis Consortium
Johns Hopkins University · USUniversity Medical Center Groningen · NLUniversity of Leicester · GBUniversity of Tennessee Health Science Center · USYamagata University · JPAmerican Medical Group Association · USGeisinger Health System · USGonzaga University · USIcahn School of Medicine at Mount Sinai · USKaiser Permanente Moanalua Medical Center · USMonash University · AUNational Institutes of Health · USQueen Elizabeth University Hospital · GBRadboud University Nijmegen · NLShiga University of Medical Science · JPThe University of Sydney · AUUniversité Paris-Sud · FRUniversity of Aberdeen · GBUniversity of British Columbia · CAUniversity of Illinois Chicago · US

Funding

Continuation of the Coordinating Center for the Chronic Renal Insufficiency Cohort (CRIC) StudyU24DK060990 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI Amanda Hyre Anderson, Laura M Dember · 2018 to 2026
$21.5M
University of Alabama at Birmingham's Diabetes Research CenterP30DK079626 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI BARBARA A GOWER · 2013 to 2026
$19.5M
Limited Competition for the Continuation of the Chronic Renal Insufficiency Cohort (CRIC) Hopkins Clinical CenterU01DK061022 · NIDDK · JOHNS HOPKINS UNIVERSITY · PI APPEL, LAWRENCE JOHN · 2001 to 2025
$15.7M
Tulane Clinical Center for Chronic Renal Insufficiency Cohort StudyU01DK060963 · NIDDK · TULANE UNIVERSITY OF LOUISIANA · PI CHEN, JING, HAMM, L LEE · 2001 to 2025
$13.9M
Chronic Kidney Disease Prognosis Consortium (CKD-PC)R01DK100446 · NIDDK · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI JOSEF CORESH, Morgan Erika Grams · 2014 to 2026
$10.7M
Epidemiology, Pathophysiology and Treatment of Diabetic NephropathyZIADK069062 · NIDDK · NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES · PI NELSON, ROBERT G · 2009 to 2023
$10.1M
NIDDK NIH HHS P30 DK079626NIDDK NIH HHS R01 DK100446NIDDK NIH HHS U01 DK060963NIDDK NIH HHS U01 DK061022NIDDK NIH HHS U24 DK060990
6 · The paper itself

Abstract

backgroundAlthough measuring albuminuria is the preferred method for defining and staging chronic kidney disease (CKD), total urine protein or dipstick protein is often measured instead.

objectiveTo develop equations for converting urine protein-creatinine ratio (PCR) and dipstick protein to urine albumin-creatinine ratio (ACR) and to test their diagnostic accuracy in CKD screening and staging.

designIndividual participant-based meta-analysis.

setting12 research and 21 clinical cohorts.

participants919 383 adults with same-day measures of ACR and PCR or dipstick protein. MEASUREMENTS: Equations to convert urine PCR and dipstick protein to ACR were developed and tested for purposes of CKD screening (ACR ≥30 mg/g) and staging (stage A2: ACR of 30 to 299 mg/g; stage A3: ACR ≥300 mg/g).

resultsMedian ACR was 14 mg/g (25th to 75th percentile of cohorts, 5 to 25 mg/g). The association between PCR and ACR was inconsistent for PCR values less than 50 mg/g. For higher PCR values, the PCR conversion equations demonstrated moderate sensitivity (91%, 75%, and 87%) and specificity (87%, 89%, and 98%) for screening (ACR >30 mg/g) and classification into stages A2 and A3, respectively. Urine dipstick categories of trace or greater, trace to +, and ++ for screening for ACR values greater than 30 mg/g and classification into stages A2 and A3, respectively, had moderate sensitivity (62%, 36%, and 78%) and high specificity (88%, 88%, and 98%). For individual risk prediction, the estimated 2-year 4-variable kidney failure risk equation using predicted ACR from PCR had discrimination similar to that of using observed ACR. LIMITATION: Diverse methods of ACR and PCR quantification were used; measurements were not always performed in the same urine sample.

conclusionUrine ACR is the preferred measure of albuminuria; however, if ACR is not available, predicted ACR from PCR or urine dipstick protein may help in CKD screening, staging, and prognosis. PRIMARY FUNDING SOURCE: National Institute of Diabetes and Digestive and Kidney Diseases and National Kidney Foundation.

Indexed as

Reagent StripsAlbuminuriaCreatinineFemaleHumansMaleMass ScreeningMiddle AgedPrognosisProteinuriaRenal Insufficiency, ChronicSensitivity and SpecificityUrinalysisCreatinineReagent Strips

Identifiers

PMID32658569
PMCPMC7780415
OpenAlexW3040786045

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.